Subscribe To
4d molecular therapeutics announces fda clearance of ind application for 4d-150, a dual-transgene intravitreal gene therapy for patients with wet amd
initiation of 4D-150 Phase 1/2 clinical trial sites expected before year-end ...
October 6, 2021, 7:30 am
4d molecular therapeutics announces fda clearance of ind application for 4d-150, a dual-transgene intravitreal gene therapy for patients with wet amd
initiation of 4D-150 Phase 1/2 clinical trial sites expected before year-end ...
October 6, 2021, 7:30 am
4d molecular therapeutics announces fda clearance of ind application for 4d-150, a dual-transgene intravitreal gene therapy for patients with wet amd
initiation of 4D-150 Phase 1/2 clinical trial sites expected before year-end ...
October 6, 2021, 7:30 am